{"id":"W2290216613","doi":"10.1053/j.gastro.2016.02.072","title":"Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection","year":2016,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":329,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Western University","funders":"UCB Pharma; Janssen Research and Development; Genentech; Tillotts Pharma; Astellas Pharma; Shire; Novo Nordisk; IC Design Education Center; Optimer Pharmaceuticals; Janssen Scientific Affairs; Ironwood Pharmaceuticals, Incorporated; Amgen; Boehringer Ingelheim; Schering-Plough; ActoGeniX; Janssen Biotech; Teva Pharmaceutical Industries; Meso Scale Diagnostics; Takeda Pharmaceutical Company; AbbVie; Procter and Gamble; Novartis; Celgene; BioClinica; Pfizer; Biogen; GlaxoSmithKline; Orexigen Therapeutics; Eli Lilly and Company; Bristol-Myers Squibb; Abbott Laboratories; Gilead Sciences","keywords":"Infliximab; Medicine; Crohn's disease; Resection; Disease; Surgery; Gastroenterology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003295216,0.0002118791,0.0007668096,0.0001914116,0.0001573062,0.0003202393,0.0001919522,0.0003610334,0.001214455],"category_scores_gemma":[0.001341705,0.0001112222,0.0003701162,0.0001716617,0.0001791185,0.0002455593,0.00011472,0.0006011603,0.0002218701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001761758,"about_ca_system_score_gemma":0.0001266874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004092486,"about_ca_topic_score_gemma":0.001194278,"domain_scores_codex":[0.9997826,0.00009518298,0.0000221239,0.00001659135,0.00003696603,0.00004655818],"domain_scores_gemma":[0.999415,0.0001660254,0.0001893912,0.00004744036,0.00004891361,0.00013307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1608281,0.007002781,0.1289203,0.00177297,0.002780362,0.001703256,0.0005785167,0.001136572,0.1304753,0.0002820428,0.004330951,0.5601889],"study_design_scores_gemma":[0.006394887,0.05531929,0.9062081,0.0001439046,0.001278375,0.002030667,0.0004309684,0.001016553,0.01901514,0.0001891885,0.007939579,0.00003334242],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901064,0.007898253,0.0001296588,0.0003590857,0.00008854896,0.00001156443,0.00004781535,0.00004499193,0.001313724],"genre_scores_gemma":[0.9982546,0.0007628002,0.0001119714,0.0001037196,0.00004879215,0.000004333949,0.00009578728,0.000003750613,0.0006141571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001214455,"threshold_uncertainty_score":0.004062712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01413060744020989,"score_gpt":0.2844641722237679,"score_spread":0.270333564783558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}